CRYSTALLINE S4 FORM OF A PLK4 INHIBITOR (1R,2S)-(E)-2-(3-(4-((CIS-2,6-DIMETHYLMORPHOLINO)METHYL)STYRYL)-1 H-IMIDAZOL-6-YL)-5'-METHOXYSPIRO[CYCLOPROPANE-L,3'-INDOLIN]-2'-ONE FUMARATE
MA55767AUndetermined Publication Date: 2022-03-02UNIV HEALTH NETWORK
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA55767
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-04-24
- Filing Date
- 2020-04-23
- Publication Date
- 2022-03-02
Need to check novelty before this filing date? Find Prior Art
No text content released.